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Abstract
Background: The objective of this study was to study the association of early age at menopause
with pulse pressure (PP), a marker of arterial stiffness, and PP change.
Methods: The effect of natural menopause was studied in 2484 women from the Atherosclerosis
Risk in Communities (ARIC) Study who had not used hormone replacement therapy and who had
not had a hysterectomy. The cross-sectional association of age with PP was evaluated in the entire
cohort. The cross-sectional association of recalled age at menopause was evaluated in the 1688
women who were postmenopausal at baseline. PP change over 6 years was assessed in relation to
menopausal age separately in women who were postmenopausal at baseline and in those whose
menopause occurred during the 6-year interval.
Results:  Chronological age was strongly and positively associated with PP in cross-sectional
analyses, but not independently associated with PP change. While menopausal age was not
associated cross-sectionally with PP, early age at menopause (age<45) was significantly and
independently associated with a slightly larger increase in PP (8.4, 95% CI 7.0–9.8) than later
menopause (6.5, 95% CI 5.8;7.2). However, among normotensive women the difference was not
statistically significant (p = 0.07, 6.1 vs 4.7).
Conclusions: Early age at menopause may be related to a greater increase in arterial stiffness, but
the effect appears to be small and further evidence is needed.
Background
Pulse pressure, i.e. the difference between systolic (SBP)
and diastolic blood pressure (DBP), is a crude but readily
acquired measure of arterial stiffness. Recent findings
from the Framingham study have suggested pulse pressure
being superior to SBP and DBP in predicting CHD risk [1].
Increased arterial stiffness has been proposed as a marker
or mechanism for initiation or progression of atheroscle-
rosis and/or structural arterial changes due to hyperten-
sion [2]. Arterial stiffness estimated with ultrasound
measured arterial diameter change, adjusted for blood
pressure, was found to be higher in boys and men than in
girls or women up to the age of 50–54 years, whereas
these differences disappeared thereafter [2,3]. Menopau-
sal factors, or loss of ovarian function, have been pro-
posed to close the gap of the gender difference in arterial
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stiffness after age 50. Early menopause may hasten the in-
crease in arterial stiffening with age, and lead to an in-
creased risk of cardiovascular mortality. A Dutch study
showed a 2 % decrease in cardiovascular mortality associ-
ated with each year's delay in menopause [4]. A Norwe-
gian study estimated a substantial protective effect of late
menopause, with 60% fewer cardiovascular deaths among
women reaching menopause at age 47 years or later [5].
In the current study we hypothesized that early age at
menopause is associated with increased arterial stiffness
as indicated by pulse pressure and with increasing pulse
pressure over time.
Material and methods
The ARIC Study [8] is a prospective study of 15,792 45–64
year old men and women in four US communities: For-
syth County, North Carolina; Jackson, Mississippi; select-
ed suburbs of Minneapolis, Minnesota; and Washington
County, Maryland. Initial participant response rates were
46% for Jackson and 66% for other three communities.
The baseline examination of the ARIC study was conduct-
ed in 1987–89, and follow-up examinations occurred in
1990–92 and 1993–95. At the baseline, sitting blood pres-
sure, anthropometry, venipuncture (12-hour fasting) and
interviews concerning medical and reproductive history
and medication use were performed. The accuracy of in-
formation pertaining to medication use was enhanced by
asking the participants to bring containers of all medica-
tions used in the previous two weeks to the ARIC clinic to
be transcribed by interviewers.
Three sitting blood pressure readings were recorded after
5 minutes of rest using a random zero sphygmomanome-
ter. The systolic and diastolic blood pressure values used
in the analysis as outcomes were averages of the second
and third readings.
The total population at baseline included 8710 women.
Women were classified as pre-, peri- or postmenopausal at
baseline. Premenopausal women were those who report-
ed that they had menstrual periods in the past 2 years, and
had not reached menopause, or who reported no missing
periods during last 2 years. Perimenopausal women were
defined as those who reported that they had reached men-
opause but also reported any menstrual periods in the
past 2 years. Women were defined as naturally postmeno-
pausal if they had not been menstruating for the past 2
years and reported their menopause was natural. Similar
menopausal definitions have been applied and described
in earlier ARIC studies [6,7].
We excluded 686 women with unknown menopausal sta-
tus at any visit, 21 women of ethnic origin other than Af-
rican-American or white, 548 women with missing
information on 3-year and/or 6-year follow-up, 2765
women who had ever used hormonal replacement thera-
py (HRT), 302 women coded as perimenopausal at both
baseline and 6-year follow-up or those who underwent
hysterectomy during the follow-up and 588 women who
had missing values for other analysis variables. All women
who had undergone hysterectomy prior to baseline (N =
1316) or during follow-up were excluded leaving 2484
women in the study population. The rationale for exclud-
ing women who had ever used HRT, those who had a hys-
terectomy, and those who remained perimenopausal at
the end of the study, was to study the effect of untreated
natural menopause. A greater proportion of women in the
excluded sample were black, fewer had a high school edu-
cation, and fewer had used antihypertensive medications
than women in the included sample.
In the final study sample, age at natural menopause was
reported at baseline by 1,688 postmenopausal, non-hys-
terectomized women. Since there might be differences by
the centers in the time between follow-up visits and other
factors, adjustments by ARIC field center were performed
by using three dummy variables in most of the models.
Because pulse pressure is affected by hypertension per se
and hypertensive medication, we divided women into
consistent users of hypertensive medication and all oth-
ers. Consistent users included women who reported hy-
pertensive medication use at baseline and each follow-up
visit.
Chronological age was evaluated in the entire study pop-
ulation (2484 women) in relation to PP level at baseline
and at the 6-year follow up examination (cross-sectional
analysis) and also in relation to the 6-year change in PP
(longitudinal analysis). Both PP level and PP change were
studied similarly in relation to recalled age at menopause
in the 1688 women who were menopausal at baseline. Fi-
nally, PP change was analyzed in relation to recorded age
at menopause in the 259 women who underwent meno-
pause between the baseline examination and the 6-year
follow up examination.
In order to adjust the 6-year change in pulse pressure for
confounding factors, analysis of covariance was per-
formed. Pulse pressure change was the dependent varia-
ble; age at menopause was the independent variable and
baseline age, baseline pulse pressure, race, hypertensive
medication use, ARIC field center and smoking were the
covariates considered.
When fitting by ordinary techniques models of change in
an outcome variable as a function of some exposure and
the baseline level of the outcome variable, it is well known
that the presence of measurement error in the baselineBMC Women's Health 2002, 2 http://www.biomedcentral.com/1472-6874/2/6
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outcome variable can cause substantial bias in the esti-
mates of all model coefficients [9]. One method to correct
the measurement error is to replace the baseline values of
the outcome variable by Stein estimates of the true values
of that variable, and then apply ordinary least squares [9].
In correcting for measurement error we have used esti-
mates for repeatability of SBP, DBP and PP from a sample
of 363 ARIC female participants with repeat measure-
ments 1–2 weeks apart during ARIC visit 3. The correla-
tion coefficients for repeat measurements of SBP, DBP
and PP were 0.75, 0.62 and 0.66, respectively.
Due to the possibility of varying prevalence of hyperten-
sive subjects in different age-groups to confound pulse
pressure change estimates, we also studied PP change as %
from baseline. Secondly, we considered the possibility of
age at menopause being significant variable when using it
as continuous in the multivariate models. Thirdly, formal
analyses to consider potential interaction between hyper-
tension status at baseline or use of hypertensive medica-
tion and menopausal age have been performed also.
Results
Among the women who were postmenopausal at base-
line, there was no cross-sectional association of pulse
pressure with recalled age at menopause (Table 1). Longi-
tudinally, the 6-year increase in PP was greatest among
those who had undergone menopause at the earliest age,
25 to 35 years, though the overall linear trend was not sta-
tistically significant. Women recalling their menopausal
age as younger than 45 years had a significantly higher PP
increase (8.0) than women recalling their menopausal age
as 45 years or older (6.6), after adjusting for age at base-
line, baseline PP, race and hypertensive medication use.
PP change for earlier (< 45 years) menopausal women was
significantly (p = 0.014) higher (8.4) than PP change for
women menopausal at age 45 or older (6.5) after taking
into account measurement error. However, among nor-
motensive women the difference was not statistically sig-
nificant (p = 0.07, 6.1 vs 4.7). Age at menopause was also
used as continuous variable in the models explaining
pulse pressure change, but it was not significant.
When pre- or perimenopausal women at least 45 years of
age at baseline were followed for 6 years, those with lower
estimated age at menopause did not have greater PP in-
crease over time compared to women with higher estimat-
ed age at menopause (Table 2).
In the cross-sectional analyses, at baseline and at the 6-
year follow-up, systolic blood pressure was strongly posi-
tively associated with chronological age, but diastolic BP
varied little with age (Figure 1). Thus, the difference be-
tween SBP and DBP, i.e. pulse pressure, increased with
age. In the baseline data, average pulse pressure was 42.3
mmHg in women aged 45 to 46 years and increased mo-
notonically to 56.5 mmHg in the oldest women aged 62–
64 years (Table 3). Linear trends in both cross-sectional
associations between baseline age and baseline PP as well
as between baseline age and PP at 6-year follow-up, were
highly significant (p=.0001) even after adjusting for race
and hypertensive medication use. Longitudinally there
was a significant relationship (p=.0001) between 6-year
change in pulse pressure and chronological age at baseline
after adjustment for baseline PP, race, hypertensive medi-
cation use, ARIC field center and smoking (Table 1). This
relationship did not remain significant after additional
adjustment for measurement error (p = 0.23).
The proportional changes in pulse pressure were nearly
similar in both hypertensive and non-hypertensive sub-
jects, but the absolute values differed. The different preva-
lence of hypertensive subjects in age-groups did not
explain the results. Additionally, the interactions between
hypertensive status at baseline or use of hypertensive
medication and menopausal age were not significant in
any subgroup, with or without adjustments for other var-
iables (results not shown in tables).
Discussion
Pulse pressure, a marker of arterial stiffness, is clearly re-
lated to older chronological age. Our study suggests that
PP may also be related to older "biological age", if one
considers early age at natural menopause as a sign of bio-
logical aging. Women whose menopause occurred before
age 45 experienced a greater increase in PP than women
with menopause at later ages. This association remained
significant when taking into account chronological age,
baseline PP, race, and use of antihypertensive medica-
tions. However, the association was limited to PP change
and was not seen for PP level at baseline or 6-years later.
The PP effect appears to be slight in magnitude, approxi-
mately 2 mm Hg, so it may be detected better in longitu-
dinal than cross-sectional analyses. Longitudinal analysis
reduces the effects of extraneous variables, since each
woman serves as her own control when her baseline PP is
subtracted from her 6-year PP. Furthermore there was no
association of PP with later menopause, suggesting that
age at menopause after age 45 is not an effective marker of
biological aging. Arterial stiffening, as assessed by pulse
pressure, may offer one explanation for the findings of
others relating cardiovascular risk to menopause before
age 45[4,5].
A change in PP in relation to menopause could reflect the
gradual reduction in circulating sex hormones which oc-
curs at the time of menopause. However, our earlier find-
ings provide some evidence against that interpretation [7].
There we showed that women currently undergoing the
menopausal transition had no more perimenopausalBMC Women's Health 2002, 2 http://www.biomedcentral.com/1472-6874/2/6
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change in BP than women of the same age not undergoing
the transition. Our current findings are different. They
show a greater PP increase after a baseline examination in
women who recalled their menopausal age as younger
than 45 years compared with similar women with later
menopausal ages. We interpret this postmenopausal PP
increase as suggesting that early menopause may be an in-
dicator of a more rapid biological aging process, i.e. that
women with an early menopause are generally aging more
quickly than expected for their chronological age, as evi-
denced by the relatively rapid changes in arterial stiffness
observed postmenopausally. Earlier studies have shown
that estrogen deficiency may induce functional changes in
large arteries, but structural changes are more likely to be
seen in long-term effects [10–15].
Ours is not the first study to evaluate the effect of meno-
pausal age on pulse pressure, a surrogate marker for arte-
rial stiffness, which may serve as an indicator of
preclinical atherosclerosis. Menopause per se has been
shown to be associated with increasing stiffness of the aor-
ta, later leading to dilatation of the common carotid artery
[16]. Most earlier cross-sectional studies during the
1990's, which have addressed the relations between tim-
ing of menopause, mortality, cardiovascular mortality
and myocardial infarction, have shown significant associ-
ation between age at menopause and cardiovascular out-
comes [4,5,17,18]. Among Seventh-Day Adventists, age-
adjusted OR of death in women with natural menopause
before age 40 was 1.95 (95% CI 1.24–3.07), and the OR
decreased with increasing age at natural menopause until
Table 1: Systolic (SBP) and diastolic (DBP) blood pressure, pulse pressure (PP) and PP change by recalled age at menopause among 
non-hysterectomized women postmenopausal at baseline. N = 1688.
Baseline 6-year follow-up
Recalled age at
menopause
N Mean age at
baseline
SBP DBP PP SBP DBP PP PP change Adj1 PP change 95% CI
25–35 40 57.6 122.9 72.3 50.6 129.5 68.4 61.1 10.5 10.1 6.1–14.2
36–40 155 56.8 122.2 71.1 51.1 128.9 69.5 59.4 8.3 8.7 6.6–10.7
41–44 167 56.5 118.9 70.3 48.6 124.5 68.5 56.0 7.4 7.3 5.3–9.3
45–48 501 57.0 123.1 71.9 51.2 127.3 69.7 57.5 6.3 6.6 5.5–7.8
49–51 469 58.1 123.4 71.7 51.7 128.1 70.0 58.1 6.4 6.2 5.0–7.3
52+ 356 59.8 125.4 71.3 54.0 129.9 68.7 61.2 7.2 6.8* 5.4–8.2
1 Adjusted for baseline age, baseline PP, race, hypertensive medication use and measurement error. * Adjusted test for linear overall trend p = 0.20, 
for women menopausal at age <45 (PP change 8.4, 95% CI 7.0–9.8) vs. age = 45 (PP change 6.5, 95% CI 5.8–7.2), p = 0.014.
Table 2: Systolic (SBP) and diastolic (DBP) blood pressure, pulse pressure (PP) and PP changes by estimated age of menopause. N = 
259. Only women pre- or perimenopausal at baseline included.
Baseline 6-year follow-up
Estimated age at
menopause
N Average 
age at
baseline
SBP DBP PP SBP DBP PP PP 
change
Adj.1 PP 
change
95% CI
45–50.4 15
1
47.8 115.8 71.7 44.1 121.4 71.6 49.7 5.7 5.7 3.4–8.0
50.5–52.4 43 49.1 117.1 71.9 45.2 125.3 73.2 52.1 6.8 6.5 2.7–10.4
52.5–54.4 37 50.3 117.8 72.5 45.3 122.9 73.4 49.5 4.2 4.1 -0.2–8.4
54.5–65.5 28 52.0 123.2 74.4 48.8 128.3 73.6 54.7 5.92 6.73 1.3–12.1
1 Adjusted for baseline age, baseline PP, race, hypertensive medication use and ARIC field center. 2 Test for overall linear trend p = 0.87. 3 Test for 
overall linear trend p = 0.74.BMC Women's Health 2002, 2 http://www.biomedcentral.com/1472-6874/2/6
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age 55[17]. In two studies, cardiovascular mortality has
been found to be greater in women with age at meno-
pause lower than 45 years as compared to women with
later age at menopause [4,5]. One recent study reported
slightly increased risk of total mortality (adjusted mortal-
ity rate ratio 1.50, 95% CI 0.97–2.34) among women with
a natural menopause at age 40 or before as compared to
women who were menstruating to age 50 or later [18].
Spontaneous cessation of ovulatory function before age
45 was associated with increased risk of myocardial infarc-
tion (RR 2.1, 95% CI 1.3–3.2) as compared with women
who had a natural menopause at age 50 or older [19]. In
Nurses' Health Study, age at menopause lower than 35
years was associated with increased risk of myocardial in-
farction, but natural menopause at later ages was not [20].
Earlier longitudinal studies [21–25] have addressed the
question of menopause and hypertension as well. Accord-
ing to the Framingham study menopause was not accom-
panied with changes in blood pressure [21]. In a Swedish
and Pittsburgh cohort studies [22,23] the findings corre-
lated Framingham study results. A Dutch cohort including
a selected sample of women also concluded that meno-
pause is not a possible cause of hypertension [24,25], al-
though ovarian failure seemed to reverse temporarily the
increase in blood pressure due to aging. In a recent longi-
tudinal study by Scuteri et al [26], postmenopausal wom-
en using HRT had a smaller increase in systolic blood
pressure than women not using HRT.
Opposite to the findings of longitudinal studies, a large
number of studies measuring either diameter, compli-
ance, distensibility of large arteries or aortic pulse wave ve-
locity have concluded that menopause per se is associated
with loss of aortic elasticity, over and above the effects of
aging [27–33].
On the basis of studies using other measurements de-
scribed above, there are limitations in the use of pulse
pressure as an index of stiffness. Pulse pressure is deter-
mined by a number of factors apart from arterial stiffness
including heart rate, stroke volume, and ejection time. Re-
sults might have been different with a more sensitive
measurement of arterial stiffness. Studies, which have as-
sessed menopause and arterial stiffness using carotid ul-
trasound measurements, provide some support for our
findings, although the relationship between timing of
menopause and change in stiffness was not assessed in
any of the described studies [34–37]. Stiffness was found
to be significantly greater in postmenopausal than age-
matched premenopausal women in the Dutch study [34].
Menopause had an independent significant association to
the stiffness index in the Swedish study [35]. In the
Healthy Women Study from Pittsburgh [36] premenopau-
sal values of pulse pressure were independently predictive
of plaque.
Since the ARIC cohort was limited to persons aged 45 or
older, our findings relating to menopause before age 45
had to depend on recall, which may be imprecise. Recall
errors may increase with time from the menopause [37],
but appear not to be related to educational status or age at
interview [38]. Imprecision in recalled age at menopause
may have attenuated our findings somewhat.
Factors known to be associated with early age at meno-
pause are smoking [39,40], low sociodemographic status
[41], nulliparity [42,43] and leanness [44], although the
effect of the latter may be partlyexplained by larger pro-
portion of smokers among lean women. In our study,
smoking did not explain the association between early age
at menopause and pulse pressure change. Multiple trig-
gers are known to lead to reproductive decline, but there
is no consensus about an ultimate pacemaker of the men-
Table 3: Pulse pressure (PP) and PP changes by chronological age at baseline among non-hysterectomized women. N = 2484.
Age at
baseline
N Adjusted PP at
baseline1
Adjusted PP at
 6-year follow-up1
AdjustedPP
 change2
Adjusted PP change 
corrected 
for measurement 
error3
95% CI
45–46 206 42.3 47.4 5.1 6.2 4.5–8.0
47–49 266 44.0 48.7 4.7 5.2 3.6–6.7
50–52 364 45.9 51.1 5.3 5.4 4.1–6.7
53–55 398 48.2 53.5 5.3 5.1 3.9–6.4
56–58 442 50.6 57.6 7.0 6.6 5.5–7.8
59–61 418 53.7 61.0 7.2 7.0 5.8–8.3
62–64 390 56.51 64.12 7.63 7.3 6.0–8.6
1 Test for overall linear trend, adjusted for race and hypertensive medication use, p = 0.7149 2 Test for overall linear trend, adjusted for baseline 
PP, race, hypertensive medication use, ARIC field center and smoking, p = 0.64 3 Additionally corrected for measurement error, p = 0.23.BMC Women's Health 2002, 2 http://www.biomedcentral.com/1472-6874/2/6
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opausal transition [45]. One view maintains that the hy-
pothalamic-pituitary changes that accompany
menopause are a consequence of compromised ovarian
function, whereas another view emphasizes age-related
changes in the nervous system as initiators of menopausal
transition [42]. Our study suggests that, whatever the rea-
sons for early age at menopause, it appears to be inde-
pendently and significantly related to a small subsequent
increase in PP, but clearly, confirmation of this interesting
finding is required.
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